Immco Diagnostic LLC (Immco) and Primus Corporation (Primus) have agreed to pay $2.375 million

Summary

A press release from USAO - New York, Western, published September 3, 2025, in which U.S. Attorney Michael DiGiacomo announces that Immco Diagnostic LLC (Immco) and Primus Corporation (Primus) have agreed to pay $2.375 million to resolve False Claims Act allegations about Paycheck Protection Program (PPP) loans. The United States contends that Immco and Primus were ineligible for second draw PPP loans because, together with their affiliates, the two companies had more than 300 employees. The release says that Immco and Primus were owned and controlled by Trinity Biotech plc, a company based in Ireland. It quotes the U.S. Attorney as saying $1.8 million in forgiven loans was obtained, and states that the claims resolved by the settlement are allegations only.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

BUFFALO, N.Y.
– U.S. Attorney Michael DiGiacomo announced today that Immco Diagnostic LLC (Immco) and Primus Corporation (Primus) have agreed to pay $2.375 million to resolve False Claims Act allegations that they improperly obtained Paycheck Protection Program (PPP) loans from the U.S. Small Business Administration (SBA) for which they were not eligible.
In March of 2020 Congress created the PPP to provide emergency financial assistance to American businesses suffering from the economic effects of the COVID-19 pandemic. A PPP loan was both forgivable and guaranteed by the SBA.  One of the requirements for a business to obtain a second draw PPP loan, was the business had to have 300 or fewer employees.
In 2021, both Immco and Primus obtained second draw PPP loans. When Immco and Primus made their loan applications and again when they sought loan forgiveness, they were owned and controlled by Trinity Biotech plc (Trinity), a company based in Ireland with multiple subsidiaries worldwide. Trinity and its affiliates, which included Immco and Primus, had over 300 employees when they applied for the loans and corresponding forgiveness. The United States therefore contends that Immco and Primus were ineligible for these loans because, together with their affiliates, they had more than 300 employees, in violation of the PPP rules.
“PPP was designed to support small business during the COVID-19 pandemic, but these companies failed to disclose accurate information about their size and eligibility thereby obtaining $1.8 million in forgiven loans that they were not entitled to,” said U.S. Attorney DiGiacomo. “This office is committed to recovering taxpayer dollars that were improperly obtained by through the PPP.”
This matter was handled by Assistant U.S. Attorneys David M. Coriell and Jonathan W. Ferris, and Investigator Margaret McFarland, with assistance from the SBA’s Office of General Counsel.
Individuals with information about allegations of fraud involving COVID-19 are encouraged to report it by calling the Department of Justice’s National Center for Disaster Fraud (NCDF) Hotline at 866-720-5721 or via the NCDF Web Complaint Form at:
https://www.justice.gov/disaster-fraud/ncdf-disaster-complaint-form
.
The claims resolved by the settlement are allegations only; there has been no determination of liability.
# # # #

File and source

File

2025-09-03_foreign-owned-companies-to-pay-2-3-million-to-resolve-false-claims-act-a_08c9ddda.md.txt

Size

2,367 bytes

SHA-256

ea5df7987adffeda0d2a21425c421973f20ceca622d6b265bb39a18c856ff7e2

Our copy

2025-09-03_foreign-owned-companies-to-pay-2-3-million-to-resolve-false-claims-act-a_08c9ddda.md.txt

Original

www.justice.gov